(Q44123964)

English

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

author name string

M Baudard

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Vincent

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

P Moreau

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

M F Kergueris

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

J L Harousseau

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

N Milpied

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

287-295

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703633

0 references

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

How I treat chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

Cytomegalovirus ventriculoencephalitis presenting as a Wernicke's encephalopathy-like syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

21 January 2018

New strategies in GVHD prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic method for the determination of mycophenolate mofetil in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of a new immunosuppressant, mycophenolate mofetil, and its active metabolite, mycophenolic acid, in rat and human body fluids by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Current opinions on therapeutic drug monitoring of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703633

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703633

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44123964&oldid=2106829890"